NCT03058744View on ClinicalTrials.gov

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions

Psoriasis

Interventions

DRUG

IDP-118 Lotion

Lotion

DRUG

HP Monad Lotion

Lotion

DRUG

Ultravate Cream

Cream

DRUG

Tazorac Cream

Cream

Trial Locations (12)

10001

Valeant Site 06, New York

19019

Valeant Site 11, Philadelphia

30301

Valeant Site 08, Atlanta

32065

Valeant Site 10, Orange Park

32771

Valeant Site 09, Sanford

46168

Valeant Site 04, Plainfield

73301

Valeant Site 03, Austin

77449

Valeant Site 02, Katy

91436

Valeant Site 05, Encino

92093

Valeant Site 01, San Diego

92801

Valeant Site 12, Anaheim

95401

Valeant Site 07, Santa Rosa

All Listed Sponsors

lead

Bausch Health Americas, Inc.

INDUSTRY

NCT03058744 - Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter